C. Mbuila , N. Beydon , F. Kamba , L. Mangyanda , L. Lukuni , B. Chatue , A. Personne , E. Blimpo , S. Goulhamhoussen , P. Hayat
{"title":"Asthme sévère : démarche diagnostique et thérapeutique. À propos d’une observation","authors":"C. Mbuila , N. Beydon , F. Kamba , L. Mangyanda , L. Lukuni , B. Chatue , A. Personne , E. Blimpo , S. Goulhamhoussen , P. Hayat","doi":"10.1016/j.allerg.2008.07.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Case report</h3><p>In a 16-year-old teenager hospitalized with a severe asthma attack, the diagnosis of severe asthma associated to allergy and current tobacco smoke and allergen exposure is confirmed. Despite the use of high dose of inhaled antiasthma medication, the disease remains uncontrolled and anti-IgE, omalizumab treatment is started. After few weeks, respiratory symptoms and function dramatically improve.</p></div><div><h3>Conclusion</h3><p>Severe asthma must be readily diagnosed in order to adapt treatment and avoid fatal outcome or respiratory disability.</p></div>","PeriodicalId":92953,"journal":{"name":"Revue francaise d'allergologie et d'immunologie clinique","volume":"48 8","pages":"Pages 554-557"},"PeriodicalIF":0.0000,"publicationDate":"2008-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.allerg.2008.07.005","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue francaise d'allergologie et d'immunologie clinique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0335745708001883","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Case report
In a 16-year-old teenager hospitalized with a severe asthma attack, the diagnosis of severe asthma associated to allergy and current tobacco smoke and allergen exposure is confirmed. Despite the use of high dose of inhaled antiasthma medication, the disease remains uncontrolled and anti-IgE, omalizumab treatment is started. After few weeks, respiratory symptoms and function dramatically improve.
Conclusion
Severe asthma must be readily diagnosed in order to adapt treatment and avoid fatal outcome or respiratory disability.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
